Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human T-lymphotropic virus type 1 infection.

K Tsukasaki1, P Koeffler, M Tomonaga

  • 1Department of Medicine, UCLA School of Medicine, CA, USA.

Bailliere'S Best Practice & Research. Clinical Haematology
|August 16, 2000
PubMed
Summary

Human T-cell lymphotropic virus type-1 (HTLV-1) causes adult T-cell leukaemia/lymphoma (ATL) and other diseases. While HTLV-1 prevention is improving, effective ATL therapies remain elusive, with complex multi-step development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Association of Muscle Strength and Gait Speed with Cross-Sectional Muscle Area Determined by Mid-Thigh Computed Tomography - A Comparison with Skeletal Muscle Mass Measured by Dual-Energy X-Ray Absorptiometry.

The Journal of frailty & aging·2020
Same author

Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.

Bone marrow transplantation·2017
Same author

Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.

Drugs of today (Barcelona, Spain : 1998)·2011
Same author

LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.

Leukemia·2011
Same author

Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.

Leukemia·2009

Area of Science:

  • Virology
  • Oncology
  • Immunology

Background:

  • Human T-cell lymphotropic virus type-1 (HTLV-1) is linked to adult T-cell leukaemia/lymphoma (ATL).
  • HTLV-1 also causes non-malignant conditions like HTLV-1 associated myelopathy and uveitis.
  • The virus is endemic in regions including southern Japan and the Caribbean.

Purpose of the Study:

  • To summarize the current understanding of HTLV-1 infection, its associated diseases, and the pathogenesis of ATL.
  • To highlight the challenges in ATL treatment and the known mechanisms of leukaemogenesis.

Main Methods:

  • Review of existing literature on HTLV-1, ATL, and related conditions.
  • Analysis of the molecular mechanisms involved in ATL development, including genetic mutations and viral integration.

Related Experiment Videos

Main Results:

  • HTLV-1 transmission occurs via breastfeeding, sexual contact, and blood transfusions.
  • Primary prevention strategies have shown success in endemic areas.
  • ATL development is a multi-step process, often involving mutations in tumor suppressor genes like p53 and p16(INK4A), and requires monoclonal integration of HTLV-1 proviral DNA.

Conclusions:

  • Despite successful prevention of HTLV-1 infection, ATL remains a significant challenge with no effective current therapies.
  • The exact mechanisms driving ATL leukaemogenesis are not fully understood but involve genetic alterations and viral integration.
  • Further research is needed to develop effective treatments for ATL.